Acorah Software Products - Accounts Production 15.0.600 false true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 13146970 Dr Yasir Al-Athari Mrs Mina Mahawish iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13146970 2023-01-31 13146970 2024-01-31 13146970 2023-02-01 2024-01-31 13146970 frs-core:CurrentFinancialInstruments 2024-01-31 13146970 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13146970 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 13146970 frs-bus:Micro-entities 2023-02-01 2024-01-31 13146970 frs-bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 13146970 frs-bus:Director1 2023-02-01 2024-01-31 13146970 frs-bus:CompanySecretary1 2023-02-01 2024-01-31 13146970 2022-01-31 13146970 2023-01-31 13146970 2022-02-01 2023-01-31 13146970 frs-core:CurrentFinancialInstruments 2023-01-31
Registered number: 13146970
Yclinic Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2024
Sam & Co Accountants
Accountant's Report
In accordance with the engagement letter dated , and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled the financial statements of the company from the accounting records and information and explanations you have given to us.
This report is made to the director in accordance with the terms of our engagement. Our work has been undertaken to prepare for approval by the director the financial statements that we have been engaged to compile, to report to the director that we have done so, and to state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's director for our work or for this report.
You have acknowledged on the balance sheet as at year ended 31 January 2024 your duty to ensure that the company has kept proper accounting records and to prepare financial statements that give a true and fair view under the Companies Act 2006. You consider that the company is exempt from the statutory requirement for an audit for the year.
We have not been instructed to carry out an audit of the financial statements. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
SAM AND CO ACCOUNTANTS
17/10/2024
Sam & Co Accountants
MAAT membeship no :20422130 & ACPA Membership No: 01298415A
479 Chester Road
Old Trafford
Manchester
M16 9HF
Page 1
Balance Sheet
Registered number: 13146970
2024 2023
£ £
Current assets 15,675 18,571
Creditors: Amounts Falling Due Within One Year (12,737 ) (14,611 )
NET CURRENT ASSETS 2,938 3,960
TOTAL ASSETS LESS CURRENT LIABILITIES 2,938 3,960
NET ASSETS 2,938 3,960
CAPITAL AND RESERVES 2,938 3,960

Notes

1. General Information
Yclinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13146970 . The registered office is 4 Mill Lane, Cheadle Hulme, Cheadle, SK8 5PG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
3. Directors Advances, Credits and Guarantees
Dividends paid to 
2024 2023
£ £
Dr Yasir Al-Athari 25,500 31,100
4. Dividends paid to shareholders
Mrs Mina Mahawish as a company shareholder has received a total of £25,500 dividend
Page 1
Page 2
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Yasir Al-Athari
Director
17/10/2024
Page 2